# Efficacy Study of AlphaBRAIN Administered Orally

> **NCT02739139** · PHASE2 · COMPLETED · sponsor: **Onnits Labs, LLC** · enrollment: 73 (actual)

## Conditions studied

- Cognitive Functioning

## Interventions

- **DIETARY_SUPPLEMENT:** AlphaBrain

## Key facts

- **NCT ID:** NCT02739139
- **Lead sponsor:** Onnits Labs, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2016-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02739139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02739139, "Efficacy Study of AlphaBRAIN Administered Orally". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02739139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*